Demant
ESRS disclosure: ESRS S1 \ DR S1-1 \ Paragraph 20
Tags Tree
- Provide a detailed account of your organization's human rights policy commitments as they pertain to your own workforce. This should include an explanation of the processes and mechanisms in place to ensure adherence to the UN Guiding Principles on Business and Human Rights, the ILO Declaration on Fundamental Principles and Rights at Work, and the OECD Guidelines for Multinational Enterprises. Emphasize the aspects that are materially significant and outline your general approach to these commitments.
-
Question Id: S1-1_03
Our Third Party Compliance Code outlines our expectations toward suppliers and business partners regarding working conditions for workers in the value chain. This includes the core International Labour Organization (ILO) standards on working conditions, workplace health and safety, freedom of association, forced/child labour and non-discrimination.
Report Date: 4Q2024Relevance: 50%
- Provide detailed information regarding the intended or achieved positive outcomes of programmes or processes designed to benefit your own workforce, as outlined in Disclosure Requirement S1-4. This should include any initiatives or processes aimed at delivering positive impacts based on the needs of your workforce, and progress in their implementation.
-
Question Id: S1-4_17
Our global recruitment platform contains embedded materials designed to prompt inclusive recruitment behaviour. Furthermore, we have expanded training in unconscious bias, inclusive leadership and psychological safety, and we have developed the capabilities of our HR leaders to drive DE&I-related topics and training locally. To support this, DE&I-specific themes of relevance for our employee performance dialogue have been part of the global process for performance dialogue since the beginning of 2023. This provides input to assess the effectiveness of our actions on DE&I, which is also evaluated through our Pulse survey, as it has specific questions regarding inclusion and fair treatment.
Report Date: 4Q2024Relevance: 85%